Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Chemotherapy-induced Cognitive Disorders During the Treatment of Hematological Malignancies

NCT07147621 is registered in ClinicalTrials.gov with University Hospital, Angers as lead sponsor.

NCT NCT07147621
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07147621 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Chemotherapy-induced Cognitive Disorders During the Treatment of Hematological Malignancies
Lead sponsor
University Hospital, Angers
Phase
Observational
Overall status
Recruiting
Start date
February 26, 2026
Completion date
October 31, 2027
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia, hodgkin's lymphoma, non-hodgkin's lymphoma